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Hepatic autophagy is differentially regulated in
periportal and pericentral zones - a general
mechanism relevant for other tissues?
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Abstract
Background: Liver zonation, the fact that metabolic pathways are spatially separated along the liver sinusoids, is
fundamental for proper functioning of this organ. For example, glutamine synthesis from glutamate and ammonia
is localized pericentrally in only 7% of the hepatocytes concentrically arranged around the central veins. Recently,
we found that FOXO transcription factors lead to upregulation of glutamine synthetase expression inducing
autophagy via increasing glutamine production. Since in liver this mechanism can only be functioning in the
pericentral zone it remains unclear how autophagy might be regulated in the rest of liver parenchyma.
Presentation of the hypothesis: We hypothesize that the regulation of autophagy by glutamine in liver is
zonated. In the periportal zone, autophagy is inhibited by low intracellular glutamine but high essential amino
acids, while in the pericentral zone it is stimulated by high intracellular glutamine. This zonation may be controlled
by the Wnt and Hedgehog signalling pathways through reciprocal influence on the expression of amino acid
transporters and metabolic enzymes in the different zones of the parenchyma.
Testing the hypothesis: The hypothesis can be tested in transgenic mice with conditional hepatocyte-specific
modulation of Wnt and Hedgehog signalling. Isolated periportal and pericentral hepatocyte populations allow for
determining the different activities of autophagy and its regulating mechanisms in different zones of the
parenchyma.
Implications of the hypothesis: Zonation of the regulation of autophagy may allow adapting the extent of the
proteolytic breakdown of proteins and organelles to different physiological needs in different zones of liver
parenchyma. In this manner metabolic functions can be supported in one zone, for example maintenance of blood
glucose levels during starvation which is a periportal issue, while simultaneously preventing cytotoxic events in the
opposite zone. Likewise, lipid metabolism can be differentially influenced by uncoupling periportal lipophagy from
pericentral breakdown of peroxisomes. Further implications concern the shaping of morphogen gradients along
the sinusoidal axis by autophagy, and the different contribution of autophagy to the development of various
different liver pathologies. The proposed dependence of the dual glutamine-dependent regulatory mechanisms of
autophagy on inverse gradients of Wnt and hedgehog signalling may be relevant for other tissues in which GS is
heterogeneously expressed.
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Autophagy, a highly conserved homeostatic mechanism
for the degradation and recycling of bulk cytoplasm,
long-lived proteins and organelles [1], is triggered and
modulated by a plethora of different stimuli such as nu-
trient deprivation and other stress signals. One such
mechanisms that has recently been revealed [2] com-
prises a signalling cascade initiated by FOXO transcrip-
tion factors that leads to transcriptional upregulation of
glutamine synthetase (GS) expression, increasing enzyme
activity and, therefore, glutamine production. By using
different autophagic markers that label autophagosome
formation, it was confirmed that FOXO-dependent acti-
vation of GS induces autophagy [2]. In the liver, this
mechanism seems to be restricted to the pericentral
zone for several reasons. First, GS expression is con-
trolled by Wnt signalling [3,4] and, thus, is found in
approximately 7% of the hepatocytes exclusively local-
ized around the central vein where the gradient of Wnt
signalling is culminating [3,5]. Second, FOXO3 is also
predominantly localized and activated in the pericentral
zone [5].
But what about the remaining 93% of the hepatocytes?
Which mechanisms might dominate the control of
autophagy in the majority of liver parenchyma? Up to
now, there is no answer to this question. However, since
early and recent measurements on the regulation of
autophagy in whole liver have revealed downregulation
of autophagic protein degradation by exposure to glu-
tamine [6,7], a mechanism opposite to FOXO-mediated
autophagy seems likely. It should be emphasized that
this problem may hold for every tissue where expression
of GS is not uniform, but cell-type specific, such as in
kidney [8] or skin [9].
Hypothesis
On this background, the following hypothesis is
advanced:
1. Autophagy in liver is zonated being regulated by
different, but related mechanisms in the periportal
and pericentral zones of the parenchyma.
2. FOXO-mediated autophagy prevails in the
pericentral zone, while the mechanism operating
periportally, in the rest of liver parenchyma, may
resemble the bidirectional amino acid transport
mechanism suggested by Nicklin et al. [10]. This
mechanism is based on glutamine as well, but here
glutamine is postulated to act by facilitating the
cellular uptake of essential amino acids (EAA) such
as leucine which then activate mTORC1 rather than
being the primary trigger of mTORC1 as in FOXO-
mediated autophagy. Thus, we hypothesize that
autophagy is stimulated by (high) intracellular
glutamine in the pericentral zone, while it is
inhibited by (high) extracellular glutamine and EAA
in the periportal zone.
3. Hedgehog (Hh) and Wnt morphogen pathways
according to their function as master regulators of
liver metabolism [4] control the balance of
autophagy in different zones of liver parenchyma.
While Wnt signalling is associated with FOXO-
mediated autophagy through control of GS
expression [5], Hh signalling may control the
suggested periportal mechanism by regulating
respective amino acid transporters.
4. The glutamine-dependent mechanisms described for
controlling zonation do not exclude other metabolic
and hormonal signals from participating in the
regulation of autophagy through influencing
mTORC1 or other essential mediators. Such signals
may modulate the magnitude rather than the
zonation of autophagy in the given zones or cell
types, a mode of action observed for most hormones
and metabolic signals that regulate other zonated
metabolic pathways in liver such as carbohydrate or
amino acid metabolism [5,11].
Liver glutamine metabolism and zonation of
autophagy
Zonation of metabolic pathways in different areas of
liver parenchyma is of considerable importance for liver
function [11]. In order to understand the opposing ef-
fects of glutamine on autophagy proposed herein, some
fundamental features of the zonation of glutamine and
ammonia metabolism in the liver must be discussed.
Glutamine is subject to intrahepatic cycling [12]: it
enters the liver via the portal vein and the hepatic artery,
is taken up via system N which is localized periportally
[13] and degraded to ammonia and glutamate by
periportal glutaminase [14]. While ammonia is mainly
converted into urea by the periportal urea cycle
enzymes, glutamate and the remaining ammonia are
delivered to the pericentral zone and used by GS for re-
synthesizing glutamine which is exported from the
pericentral hepatocytes into the hepatic vein. This
intrahepatic cycling plays a considerable role in deter-
mining the balance of ammonia detoxification [4,14,15].
Since periportal autophagy, according to our hypoth-
esis, depends on external glutamine (and EAA), its activ-
ity may vary considerably in different nutritional states.
In contrast, pericentral FOXO-mediated autophagy may
permanently be active at a high level, because of the
constantly high intracellular concentrations of glutamine
in pericentral hepatocytes. The higher activity makes
sense, since pericentral hepatocytes usually are exposed
to more severe oxidative stress due to the predominant
expression of many cytochrome P450 isozymes in this
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the “periportal” mechanism may dominate on average,
because it is at least 10-fold more abundant in the liver
compared to FOXO-mediated autophagy which is
restricted to the GS-positive zone (< 10% of the
parenchyma). Therefore, our hypothesis provides a sim-
ple explanation for the previous findings that the average
autophagic capacity in perfused liver or cultured hepato-
cytes is downregulated by glutamine [6,7].
Implications
Autophagy is known to play a considerable role in liver
physiology and pathology [17-19]. Zonated regulation of
this process may offer not only the possibility to differ-
ently connect autophagy with anabolic and catabolic
pathways which are usually inversely zonated, but also
to influence these pathways in different ways. Since our
hypothesis includes both, metabolic regulation through
amino acids and morphogen signalling controlling the
proportion of zonated functions, the implications for
liver metabolism and pathology are very versatile. Some
examples are discussed below.
Under well nourished conditions, amino acids (includ-
ing glutamine and EAA) entering through afferent
vessels are high. The suggested regulatory mechanism
for periportal autophagy implies that part of the glutam-
ine taken up is re-exported for exchange of leucine
which subsequently inhibits autophagy by activating
mTORC1. This may favour maintenance of mitochon-
dria for optimally driving urea synthesis and keeping
nitrogen balanced. Simultaneously, pericentral FOXO-
mediated autophagy may act largely unaffected ensuring
protection against increased risk of cell deterioration
due to decreasing pericentral oxygen concentrations.
However, if such a well nourished condition continues
over time, reduced periportal autophagy may raise p62
levels compromising degradation of ubiquitine-proteasome
pathway substrates [20] and eventually resulting in liver
pathology.
During starvation, the opposite scenario is likely.
Levels of glutamine and EAA in portal blood are quite
low. Thus, little leucine may enter the periportal hepato-
cytes, mTORC1 remains inhibited and autophagy is
activated. This mechanism may contribute to the well-
known fact that the liver can maintain blood glucose
and amino acid levels by sacrificing up to 40% of its pro-
tein in an early stage of starvation [7,21,22]. This process
may include both, periportal and pericentral hepatocytes,
since glutamine production in pericentral hepatocytes is
increased due to enhanced ammonia levels. Conse-
quently, FOXO-mediated autophagy should also be
stimulated during starvation. Interestingly, repeated
starvation may cause extension of the GS-positive zone
[23] and, thus, may shift the balance between the two
regulatory mechanisms of autophagy in favour of
FOXO-mediated autophagy.
Another important issue affected by our hypothesis
concerns liver lipid metabolism. Autophagy has recently
been found to play an important role in lipid metabolism
particularly in liver, because activation may lead to
enhanced lipid degradation (also known as lipophagy
[24]), while inhibition may result in a steatotic pheno-
type [25]. However, the situation appears much more
complex. For instance, lipophagy during starvation may
have a protecting function [24] by limiting the puzzling
accumulation of triglycerides occurring during a 24 h
fasting period [26] due to flooding the liver with free
fatty acids liberated from adipose tissue. Different contri-
butions of periportal and pericentral autophagy may
explain the observed focal rather than global distribution
of lipid droplets. Furthermore, independent regulation of
pericentral autophagy as hypothesized herein offers the
possibility for independent regulation of peroxisomal
β-oxidation of fatty acids by FOXO-mediated autoph-
agy, because peroxisomes are preferentially found in
the pericentral zone. Indeed, treating fasted rats with
antilipolytic drugs resulted in changes in peroxisomal
rather than mitochondrial enzyme activities [27]. Not-
ably, peroxisome distribution can be enlarged by
dihydroepiandrosterone, a drug also enlarging the GS-
positive zone [28] and, thus, the zone of FOXO-
mediated autophagy.
The proposed dependence of the regulation of autoph-
agy on Wnt and Hh signalling is of particular interest,
since both morphogen signalling pathways can be con-
sidered as master regulators of liver zonation. This has
been demonstrated for Wnt signalling which controls
amino acid, ammonia and carbohydrate metabolism
[3,5,29] and, via FOXO3 and glutamine synthesis,
FOXO-mediated autophagy. The contribution of Hh
signalling to the control of liver zonation is still hypo-
thetical in spite of supportive data (for review see [4]). As
shown in other organs, however, Hh signalling controls
lipid metabolism in adipose tissue [30] and autophagy in
vascular smooth muscle cells [31]. We assume similar
effects to occur in liver, particularly in the periportal
zone. Further evidence suggests that autophagy may
regulate Wnt signalling by promoting Dishevelled deg-
radation [32]. Taken together, these findings may imply
that autophagy is not only subject to regulation by mor-
phogens, but conversely may contribute to shaping
graded morphogen action, an as yet unsolved problem
in liver [6]. Given the fact that liver zonation seems to
be of considerable importance for the development of
distinct phenotypic classes of hepatocellular tumors
[33,34], zonated regulation of autophagy may have more
impact on the development of liver cancer than thought
before [35].
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many tissues (prominent examples are kidney [8], skin [9],
and small intestine [36]) matching inverse gradients of
Wnt and hedgehog signalling (for small intestine see [37]),
the dual glutamine-dependent opposing mechanisms
described herein, may represent a more general principle
for balancing bulk protein turnover by autophagy.
Testing
The hypothesis outlined herein is testable, although func-
tional heterogeneity of hepatocytes in situ is hard to ap-
proach. However, periportal and pericentral subpopulations
of hepatocytes isolated by the digitonin-collagenase tech-
nique [38] may substitute and allow measuring autophagy
and its regulation in vitro according to published tech-
niques [2,10]. The contribution of Hh signaling in regulat-
i n ga u t o p h a g yc o u l db et e s t e di nt r a n s g e n i cm i c ew i t h
conditional knockout of Smoothened (down-regulation) or
of Patched (up-regulation). Conditional liver-specific regu-
lation can be achieved by promoter systems similar to those
that have been used to manipulate Wnt or TGF-beta
signaling [3,29,39]. In order to evaluate zonation, periportal
and pericentral subpopulations of hepatoctyes from these
transgenic mice again are suitable for measuring differences
in transport of amino acids, particularly glutamine, in
mTORC1 activity and other known relevant functions.
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